1. Home
  2. TLS vs BWAY Comparison

TLS vs BWAY Comparison

Compare TLS & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telos Corporation

TLS

Telos Corporation

HOLD

Current Price

$5.03

Market Cap

376.1M

Sector

Technology

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$19.02

Market Cap

337.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLS
BWAY
Founded
1969
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
376.1M
337.9M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
TLS
BWAY
Price
$5.03
$19.02
Analyst Decision
Buy
Strong Buy
Analyst Count
5
2
Target Price
$7.75
$23.50
AVG Volume (30 Days)
1.1M
65.1K
Earning Date
11-10-2025
11-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
213.09
EPS
N/A
0.13
Revenue
$144,400,000.00
$49,094,000.00
Revenue This Year
$52.27
$330.76
Revenue Next Year
$20.44
$22.24
P/E Ratio
N/A
$61.40
Revenue Growth
17.44
27.08
52 Week Low
$1.83
$7.84
52 Week High
$8.36
$19.80

Technical Indicators

Market Signals
Indicator
TLS
BWAY
Relative Strength Index (RSI) 36.96 63.20
Support Level $5.03 $18.31
Resistance Level $5.22 $19.80
Average True Range (ATR) 0.29 0.87
MACD -0.01 0.14
Stochastic Oscillator 5.95 82.38

Price Performance

Historical Comparison
TLS
BWAY

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: